Goldman Sachs

ReNew Power enters agreement with RMG II; soon to list on NASDAQ

RailTel Corporation IPO subscribed 6.55 times as the grey market dives

Piramal Group to take charge of DHFL

Asian equities witness largest foreign investments in over a decade

Walmart prepares for $10 billion Flipkart IPO in US

Goldman Sachs revises India’s GDP forecast to 10.3% for FY21

Goldman Sachs to invest Rs 1,125 crores in Biocon Biologics

Goldman Sachs will be given Optionally Convertible Debentures at a post-money equity valuation of $3.94 billion and the transaction is subject to customary approvals and limitations